<DOC>
	<DOCNO>NCT02648165</DOCNO>
	<brief_summary>Depression ( major depressive disorder ; MDD ) common mental disorder . Research suggest individual prior depressive episode risk relapse recurrence MDD . Secondary prevention identify key goal long-term management disease . The current project aim investigate whether group base Acceptance Commitment Therapy ( ACT ) reduce surrogate clinical marker relapse group highly vulnerable depressive episode . The group intervention consist eight session , group consist maximum 12 person . The project also study whether Attention Bias Modification ( ABM ) precede ACT intervention enhance effect . ABM administer fourteen day period prior ACT-intervention . Effect measure period 12 month . The primary outcome change depressive symptom . ACT-specific secondary outcome measure also include . Subjects history major depression ( n=200 ) , currently remission , recruit Sørlandet Hospital ( 100 participant ) . Matched participant ( 100 participant ) recruit University Oslo . In first phase , participant Sørlandet hospital randomize ABM treatment control condition . In second phase participant Sørlandet hospital receive group base ACT treatment . Group base ACT ABM represent intervention time cost effective , could make available large number individual struggle MDD .</brief_summary>
	<brief_title>Secondary Prevention Depression Through Group-based ACT-Therapy Preceded Experimental ABM-Procedure</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Subjects history major depression , currently remission Current past neurological illness , bipolar disorder , psychosis drug addiction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>